Combining Double Fluorescence In Situ Hybridization with Immunolabelling for Detection of the Expression of Three Genes in Mouse Brain Sections

Summary

Localizing gene expression to specific cell types can be challenging due to the lack of specific antibodies. Here we describe a protocol for simultaneous triple detection of gene expression by combining double fluorescence RNA in situ hybridization with immunostaining.

Abstract

Detection of gene expression in different types of brain cells e.g., neurons, astrocytes, oligodendrocytes, oligodendrocyte precursors and microglia, can be hampered by the lack of specific primary or secondary antibodies for immunostaining. Here we describe a protocol to detect the expression of three different genes in the same brain section using double fluorescence in situ hybridization with two gene-specific probes followed by immunostaining with an antibody of high specificity directed against the protein encoded by a third gene. The Aspartoacyclase (ASPA) gene, mutations of which can lead to a rare human white matter disease - Canavan disease - is thought to be expressed in oligodendrocytes and microglia but not in astrocytes and neurons. However, the precise expression pattern of ASPA in the brain has yet to be established. This protocol has allowed us to determine that ASPA is expressed in a subset of mature oligodendrocytes and it can be generally applied to a wide range of gene expression pattern studies.

Introduction

Glial cells, which are the most abundant cells in the central nervous system (CNS), comprise oligodendrocytes (the myelinating cells of CNS), oligodendrocytes precursors (OPs, also known as "NG2 cells"), astrocytes and microglia. There is growing interest in the functions of glial cells and their potential roles in neurological diseases¹. For example, Canavan disease (CD) is a hereditary neurodegenerative disorder starting early in infancy with spongiform leukodystrophy and a progressive loss of neurons, leading to death usually before 10 years of age^2,3. Mutations in the Aspartoacyclase (ASPA) gene that lead to drastically reduced ASPA activity⁴ in CD have been identified. ASPA is an enzyme catalysing the deacetylation of N-acetylaspartate (NAA), a molecule highly concentrated in the brain, generating acetate and aspartate ^5-7. Many CD patients show higher levels of NAA due to lack of ASPA activity. Some studies speculate that NAA-derived acetate could be a major source of fatty acids/lipids in the brain during development and CD may result from decreased myelin synthesis during development caused by the failure of NAA to be broken down^3,5,6.

ASPA is predominantly found in the kidney, liver and white matter of the brain, and given the important role of ASPA in CD, the cellular expression of this enzyme in the brain has been studied by several labs. By looking at ASPA enzymatic activity in the brain, earlier studies found that the increase in ASPA activity during brain development parallels the time course of myelination ^8-10. At the cellular level, assays for enzymatic activity as well as in situ hybridization (ISH) and immunohistochemistry (IHC) analyses suggest that ASPA is mainly expressed in oligodendrocytes in the brain but not in neurons or astrocytes^11-16. A few studies found that ASPA might also be expressed in microglia in the CNS^12,14. So far data on ASPA expression in OPs are limited. According to a recent study where transcriptomes of different cell types in the mouse cerebral cortex including neurons, astrocytes, OPs, newly formed oligodendrocytes, myelinating oligodendrocytes, microglia, endothelial cells, and pericytes were analysed by RNA sequencing¹⁷, ASPA is exclusively expressed in oligodendrocytes, in particular in myelinating oligodendrocytes (http://web.stanford.edu/group/barres_lab/brain_rnaseq.html).  Despite these studies on ASPA expression pattern in the brain, a number of uncertainties remain.

Different techniques can be used to study gene expression patterns. IHC is a commonly used method for detecting the functional product (i.e., protein) of a gene expression in tissue sections. Despite its great utility, this technique has limitations as its application and specificity are subject to the availability and specificity of the antibody needed. By comparison, ISH has the advantage of being able to reveal the expression of any gene at the mRNA level. However, it can be technically challenging to use several probes at the same time in order to localize a gene expression to specific cell types. In this article, we describe a protocol combining double fluorescence RNA in situ hybridization with fluorescence immunolabelling of a protein. We have used this set of techniques to examine the expression pattern of Aspa in mouse brain. This method allows the precise study of gene expression using confocal microscopy.

Protocol

Ethics Statement:
Mouse husbandry and handling are in accordance with UK Home Office regulations and UCL ethics committee guidelines, complying with the Animals (Scientific Procedures) Act 1986 of the United Kingdom and its Amendment Regulations 2012.

NOTE: All solutions should be made with diethyl pyrocarbonate (DEPC)- treated water to destroy any residual RNase. For DEPC treatment, add DEPC (1 ml per litre), shake vigorously until all the DEPC globules have disappeared then autoclave to degrade the DEPC.

1. RNA Probe Synthesis

1. CAUTION: When handling formamide, wear Personal Protective Equipment (PPE) and use a safety cabinet. Prepare hybridization buffer: DEPC-treated deionized water with 50% (v/v) deionized formamide, 200 mM NaCl, 5 mM EDTA, 10 mM Tris-HCl pH 7.5, 5 mM NaH₂PO₄, 5 mM Na₂HPO₄, 0.01 mg/ml yeast tRNA, 1× Denhardt's solution, and 10% w/v dextran sulfate.
2. Choose a DNA clone that contains the cDNA sequence of the gene of interest in a plasmid with RNA polymerase promoters. For this example, use a pCMV-SPORT6 clone, IRAVp968C0654D (Genbank accessionBC024934), with T7 and Sp6 RNA polymerase promoters for Aspa (Supplementary Figure 1).
3. Prepare linearized plasmid DNA as template.
   1. Grow the DNA clone, extract the plasmid with a small-scale plasmid purification kit according to the manufacturer's protocol and sequence with the T7 and Sp6 universal primers.
   2. Digest 1,020 µg plasmid DNA with a restriction enzyme that cuts at the 5' end of the sense strand of the cDNA. For this example, use 100 unit SalI to digest the pCMV-SPORT6-Aspa plasmid. Incubate for 1.5 hr at 37 ^oC.
   3. Run a small aliquot on an agarose gel to check that the plasmid is fully linearized.
4. Purify the linearized plasmid using phenol-chloroform.
   1. Add 1/10 volume of 3 M sodium acetate, one volume of 10 mM Tris HCl (pH 8.0) - equilibrated phenol and one volume of chloroform/isoamyl alcohol (IAA) (24:1).
   2. Centrifuge at 16,000 x g for 1 min at RT (20 - 25 °C, RT) and extract upper aqueous phase.
   3. Add one volume of chloroform/IAA, centrifuge at 16,000 x g for 1 min and extract upper aqueous phase.
   4. Repeat step 1.4.3.
   5. Add 2 volumes of ethanol and leave at -20^oC for 1 hr or O/N.
   6. Centrifuge at 16,000 x g at 4 °C for 10 min. Discard the supernatant.
   7. Wash the pellet with 70% cold ethanol and re-suspend at approximatively 1 µg cDNA per 2.5 µl in TE (10 mM Tris-HCl, 1 mM EDTA pH 7.5).
5. Synthesize the two probes, one labelled with Digoxigenin (DIG) and the other with fluorescein isothiocyanate (FITC ).
   1. Select the appropriate RNA polymerase to make the anti-sense probe (complementary to the target mRNA). For this example, use T7 RNA polymerase to make Aspa probe.
   2. Prepare in vitro transcription reaction: add 1 µg of the linearized DNA, 4.0 µl 5 x transcription buffer, 6.0 µl of 100 mM DTT, 2.0 µl of 10x DIG or FITC RNA labelling mix containing dNTPs, 1 µl RNase inhibitor, and 20 - 40 units of RNA polymerase; make the final volume up to 20 µl with DEPC-treated water.
   3. Incubate at 37 ^oC for 1.5 hr.
6. Run1 µl of the transcription reaction on a 1.0% agarose gel to check that the reaction has worked. The gel should show the linear template and a bright band of the probe.
7. Make the volume up to 100 µl with hybridization buffer and store 10 µl aliquots at -80 °C.

2. Perfusion, Fixation and Tissue Collection

1. CAUTION: When handling paraformaldehyde (PFA), both solid and aqueous, wear PPE and use a safety cabinet. Prepare formaldehyde solution by dissolving 4% (w/v) PFA into 1x phosphate buffered saline (PBS) solution using heat (55 °C). Filter the formaldehyde solution with filter paper.
2. Prepare sucrose solution by dissolving 20% (w/v) sucrose in distilled water and add 0.1% (v/v) DEPC solution. Leave O/N at RT with a loose lid and then autoclave.
3. Terminally anaesthetize a mouse by intra-peritoneal injection of pentobarbitone (50 mg/kg). Assess the depth of anaesthesia by toe pinch and the absence of withdrawal reflex indicates deep anaesthesia.
4. Once the mouse is under deep anaesthesia, make an incision beneath the rib cage and cut through the rib cage on both sides, lift it to expose the heart.
5. Insert a 25-G needle into the left ventricle of the heart. Make a small incision in the right atrium of the heart.
6. Perfuse the animal with 20 ml PBS and then 40 ml formaldehyde solution. For P30 and older mice, use a perfusion rate of 12 ml/ min but for younger animals use a lower rate (7 - 10 ml/min).
7. Dissect the brain.
   1. Sever the mouse head with surgical scissors by making a cut posterior from the ears. Make a caudal midline incision in the skin and work rostrally to remove the skin from skull.
   2. Starting from the caudal part, cut through the top of the skull along midline and between the eyes with Iris scissors. Remove the parietal and frontal bone plates by tilting one side of a bone plate each time and snapping it off with tweezers.
   3. Gently tilt the brain upward from the anterior part with tweezers and cut the optic nerves and other cranial nerves. Gently lift the brain out of the skull.
8. Place the brain into a mouse coronal brain matrix. Slice the brain into 3 approximately 4 mm pieces with a feather razor blade.
9. Transfer the slices into 4% PFA solution and incubate O/N at 4 °C.
10. Transfer brain slices to DEPC-treated 20% sucrose solution and incubate O/N at 4 °C
11. Place each brain slice into a dry cryomould, surround with optimum cutting temperature (OCT) medium and freeze on dry ice. Store at -80 °C.

3. Cryosectioning

1. Cut 15 µm sections of frozen tissue in a cryostat and collect the sections onto microscope slides. If required, wet the sections with DEPC-treated PBS and flatten them with a fine paintbrush.
2. Leave the slides to dry for approximately 1 hr to ensure that the tissue adheres to the slide.

4. Hybridization

1. Prepare 65 °C wash buffer: 150 mM NaCl, 15 mM Na₃C₃H₅O(COO)₃ (= 1x saline sodium citrate), 50% (v/v) formamide and 0.1% (v/v) Tween-20.
2. Prepare MABT buffer: 100 mM maleic acid, 150 mM NaCl, 0.1% (v/v) Tween-20, pH 7.5.
3. Dilute the two probes (DIG-labelled and FITC-labelled) 1/1,000 in hybridization buffer pre-warmed to 65 °C and mix well.
4. Apply around 300 µl of hybridization mixture onto each slide, coverslipwith oven-baked (200 ^oC) coverslips and incubate O/N at 65 °C in a humidified chamber.
5. Transfer the slides into a Coplin jar containing pre-warmed wash buffer. Wash the slides for 30 min twice at 65 °C with wash buffer.
6. Wash the slides for 10 min three times with MABT at RT.

5. Visualization of the FITC Probe

1. Prepare ISH blocking buffer: MABT with 2% blocking reagent and 10% heat-inactivated sheep serum.
2. Optional: use a hydrophobic pen to draw circles around the tissue sections on the slide to reduce the volume of antibody solutions required.
3. Incubate the slides for 1 hr at RT with ISH blocking buffer in a humidified chamber.
4. Incubate the slides O/N at 4 °C with a horseradish peroxidase (POD)- conjugated anti-FITC antibody diluted 1/500 (v/v) in ISH blocking buffer.
5. Place the slides into a Coplin jar containing PBS with 0.1% (v/v) Tween-20 (PBST). Wash 3 times for 10 min in PBST and replace with fresh PBST each time.
6. Immediately before use, prepare the fluorescent tyramide by diluting 100 times into the Amplification diluent. For this example, use FITC-tyramide.
7. Add this to the slides and leave for 10 min at RT.
8. Place the slides into a Coplin jar and wash 3 times in PBST for 10 min.

6. Visualization of the DIG Probe

1. Prepare 0.1 M Tris- HCl pH 8.2.
2. Incubate the slides with ISH blocking buffer for 1 hr at RT.
3. Incubate the slides O/N at 4 °C with an alkaline phosphatase (AP) -conjugated anti-DIG antibody diluted 1/1,500 (v/v) in ISH blocking buffer.
4. Wash with MABT for 10 min three times.
5. Wash twice with 0.1 M Tris-HCl pH 8.2 for 5 min at RT.
6. Immediately before use, prepare Fast Red solution by dissolving the tablets in 0.1 M Tris pH 8.2. Filter the solution through a 0.22 µM filter.
7. Incubate the slides at 37 °C with Fast Red solution in a humidified chamber. As the time for optimal development varies, check the slides regularly with a fluorescent microscope to monitor the formation of precipitate. For this example, stop the reaction after 2 - 3 hr.
8. Wash with PBST for 10 min three times.

7. Immunohistochemistry

1. Prepare IHC blocking buffer: 10% (v/v) serum (of a different species to primary antibody host) in PBST.
2. Incubate slides with IHC blocking buffer for 1 hr at RT in a humidified chamber.
3. Prepare primary antibody: dilute the primary antibody at an appropriate dilution in PBST with 5% serum (of a different species to primary antibody host). For this example, use a rabbit anti-Olig2 antibody at 1/400 (v/v) dilution.
4. Incubate in the primary antibody solution at 4 °C O/N.
5. Wash with PBST for 10 min three times.
6. Prepare secondary antibody: dilute a fluorophore-conjugated secondary antibody at an appropriate dilution in PBST with 5% (v/v) serum (of a different species to primary antibody host) and 0.1% (v/v) Hoechst 33258. For this example, use a donkey anti-rabbit Alexa647 secondary antibody at 1/1,000 (v/v) dilution.
7. Incubate in the secondary antibody solution at RT for 1 hr.
8. Wash with PBST for 10 min three times.

8. Mounting

1. Partially dry the slides at RT, and mount with a fluorescence mounting medium. Leave the slides to dry and then image in a confocal microscope under 10X, 20X and 63X objectives using 4 different channels with the following excitation wavelengths: 570 nm for Fast Red, 488 nm for FITC, 647 nm for Olig2 immunolabelling and 350 nm for Hoechst.

Results

This article describes a method for a double fluorescence ISH followed by immunolabelling in mouse brain sections. A brief description of this protocol is shown in Figure 1. The first step was to synthesize probes specific to Aspa and Mbp (myelin basic protein). To check that the probes had been synthesized, a small aliquot of each reaction was run on an agarose gel. The faint linear template and a large amount of the RNA probe can be seen (...

Discussion

This protocol provides a step-by-step procedure for a double RNA in situ hybridization followed by immunostaining. We have used this protocol to confirm that Aspa is expressed in mature oligodendrocytes in several brain areas.

This multi-step procedure has many potential pitfalls that can affect sensitivity and should be avoided. First, all the solutions and storage buffers for the transcription reaction need to be RNase-free. Second, the choice of cDNA templates is important...

Materials

Name	Company	Catalog Number	Comments
QIAprep Miniprep	Qiagen	27104
Deionized formamide	Sigma	F9037	for ISH blocking buffer
Sodium chloride	Sigma	S3014
Trizma Base	Sigma	T1503
Hydrochloric acid	VWR International	20252.290
Sodium phosphate monobasic anhydrous	Sigma	S8282
Sodium phosphate dibasic dihydrate	Sigma	30435
Yeast tRNA	Roche	10109495001
50x Denhardt's solution	Life Technologies	750018
Dextran sulfate	Sigma	D8906
Aspa cDNA clone	Source Bioscience	IRAVp968C0654D
SalI	New England Biolabs	R0138
Sodium acetate	Sigma	S2889
Equilibrated phenol	Sigma	P4557
Chloroform	Sigma-Aldrich	C2432
Isoamyl alcohol	Aldrich	496200
Ethanol	VWR International	20821.321
T7 RNA polymerase	Promega	P4074
Transcription buffer	Promega	P118B
100 mM DTT	Promega	P117B
UTP-DIG NTP mix	Roche	11277073910
Rnasin	Promega	N251B
Paraformaldehyde	Sigma	P6148
Filter paper	Fisher scientific	005479470
Sucrose	Sigma	59378
Diethyl pyrocarbonate	Sigma	D5758
Pentobarbitone	Animalcare Ltd	BN43054
Dissecting scissors	World Precision Instruments	15922
25 gauge needle	Terumo	300600
Peristaltic pump	Cole-Parmer Instrument Co. Ltd	WZ-07522-30
Iris scissors	Weiss	103227
No.2 tweezers	World Precision Instruments	500230
Coronal Brain Matrix	World Precision Instruments	RBMS-200C
Razor blade	Personna Medical	PERS60-0138
OCT medium	Tissue tek	4583
Cryostat/microtome	Bright
Superfrost plus slides	Thermo Scientific	J1800AMNZ
Sodium citrate	Sigma	S4641	for 65 °C wash buffer
Formamide	Sigma-Aldrich	F7503
Tween-20	Sigma-Aldrich	P1379
Coverslips	VWR International	631-0146
Coplin Jar	Smith Scientific Ltd	2959
Blocking reagent	Roche	11096176001
Heat-inactivated sheep serum	Sigma	S2263
Hydrophobic pen	Cosmo Bio	DAI-PAP-S	1:500
α-FITC POD-conjugated antibody	Roche	11426346910
TSA™ Plus Fluorescein System	Perkin Elmer	NEL741001KT	1:1,500
α-DIG AP-conjugated	Roche	11093274910
Fast red tablets	Roche	11496549001
.22 µM filter	Millex	SLGP033RS
α-Olig2 Rabbit antbody	Millipore	AB9610
Alexa Fluor® 647-conjugated α-rabbit antibody	Life technologies	A-31573	1:1,000
bisBenzimide H 33258	sigma	B2883
Mounting medium	Dako	S3023
Leica SP2 confocal microscope	Leica